pharmaphorum12m
5 ways to address pricing and access challenges across the European landscape
“Differently from the US, in Europe most of the reimbursement is managed at the national level, so not at the European Union ...
Pharmaceutical Technology25m
MSD makes licence agreement with Hengrui Pharma for Lp(a) inhibitor
MSD has entered an exclusive licence agreement with Hengrui Pharma for the oral small molecule Lp(a) inhibitor, HRS-5346.
Indian overseas direct investment remittances hit $36 billion in FY25
Indian firms sent $36 billion abroad via ODI in FY25, with Singapore, the US, and UK leading; February saw $5.35 billion.
Insider Media56m
Diaceutics agrees multimillion-pound contract with US firm to commercialise oncology precision medicine
Diaceutics, a Belfast-based technology and services provider to the pharma and biotech industry, has agreed a contract with the new US licence holder for the oncology precision ...
HC allows Natco Pharma to make Swiss firm Roche’s spinal muscular atrophy drug in public interest
The bench said that public good outweighs the company’s profit as the drug is not available at an affordable price in India.